ALPAU logo

Alpha Healthcare Acquisition Corp. III (ALPAU)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Alpha Healthcare Acquisition Corp. III (ALPAU) with AI Score 49/100 (Weak). Alpha Healthcare Acquisition Corp. III is a special purpose acquisition company (SPAC) focused on merging with a business in the healthcare industry. Market cap: 0, Sector: Financial services.

Last analyzed: Mar 18, 2026
Alpha Healthcare Acquisition Corp. III is a special purpose acquisition company (SPAC) focused on merging with a business in the healthcare industry. The company was incorporated in 2021 and is based in New York, aiming to identify and acquire a promising healthcare entity.
49/100 AI Score

Alpha Healthcare Acquisition Corp. III (ALPAU) Financial Services Profile

CEORajiv Sarman Shukla
HeadquartersNew York City, US
IPO Year2021

Alpha Healthcare Acquisition Corp. III is a SPAC targeting a merger within the U.S. healthcare sector. With a focus on identifying and acquiring a high-potential healthcare business, the company offers investors exposure to potential growth through its future acquisition target, operating without current significant operations.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 18, 2026

Investment Thesis

Alpha Healthcare Acquisition Corp. III presents a speculative investment opportunity tied to its ability to identify and merge with a promising healthcare company. With a market capitalization of $0.16 billion and a P/E ratio of 3.70, the company's valuation is heavily dependent on the perceived value and growth potential of its future acquisition target. A successful merger could lead to significant returns for investors, while failure to find a suitable target or a poorly executed merger could result in losses. Key catalysts include the announcement and completion of a merger agreement. The primary risk lies in the uncertainty surrounding the acquisition target and the potential for dilution or unfavorable deal terms.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market capitalization of $0.16 billion reflects investor expectations regarding a potential merger.
  • P/E ratio of 3.70 indicates market valuation relative to earnings, influenced by SPAC status.
  • Gross margin of 59.3% is not indicative of current operations but may reflect potential target company financials.
  • Profit margin of -199.6% reflects the costs associated with operating as a SPAC prior to a merger.
  • Focus on the U.S. healthcare industry provides a defined target market for acquisition efforts.

Competitors & Peers

Strengths

  • Experienced management team with healthcare expertise.
  • Access to capital through the SPAC structure.
  • Focus on a high-growth sector.
  • Flexibility to pursue various types of business combinations.

Weaknesses

  • Lack of current operating business.
  • Dependence on identifying and completing a suitable acquisition.
  • Potential for dilution through additional share issuances.
  • Competition from other SPACs.

Catalysts

  • Upcoming: Announcement of a definitive merger agreement with a target healthcare company.
  • Ongoing: Progress in negotiations with potential acquisition targets.
  • Ongoing: Favorable regulatory developments in the healthcare industry.
  • Ongoing: Positive market sentiment towards the healthcare sector.

Risks

  • Potential: Failure to identify a suitable acquisition target within the specified timeframe.
  • Potential: Unfavorable deal terms or valuation in a merger agreement.
  • Potential: Regulatory changes that negatively impact the healthcare industry.
  • Potential: Economic downturn or market volatility that reduces investor confidence.
  • Ongoing: Competition from other SPACs seeking acquisitions in the healthcare sector.

Growth Opportunities

  • Successful Merger Completion: The primary growth opportunity lies in identifying and successfully merging with a high-growth healthcare company. The size of the potential target market is substantial, with the U.S. healthcare industry representing trillions of dollars in annual spending. A well-chosen target with strong growth prospects could drive significant shareholder value, with the timeline dependent on the speed and efficiency of the acquisition process.
  • Operational Improvements Post-Merger: After completing a merger, there is an opportunity to improve the operations and financial performance of the acquired company. This could involve implementing cost-saving measures, expanding into new markets, or developing new products and services. The potential impact on shareholder value depends on the effectiveness of these efforts and the ability to generate sustainable growth.
  • Attracting Additional Investment: A successful merger can attract additional investment from institutional and retail investors, increasing the company's market capitalization and providing access to additional capital for growth initiatives. The ability to attract investment depends on the perceived value and growth potential of the combined company and the overall market sentiment towards the healthcare sector.
  • Strategic Partnerships and Alliances: Forming strategic partnerships and alliances with other companies in the healthcare industry can create new opportunities for growth and expansion. These partnerships could involve collaborations on research and development, marketing and distribution, or other areas of mutual interest. The potential benefits include increased revenue, reduced costs, and enhanced competitive positioning.
  • Expansion into New Geographies: Depending on the nature of the acquired company, there may be opportunities to expand into new geographic markets. This could involve entering new regions within the United States or expanding internationally. The potential impact on shareholder value depends on the size and growth potential of these new markets and the ability to successfully adapt to local market conditions.

Opportunities

  • Acquire a high-growth healthcare company.
  • Improve the operations and financial performance of the acquired company.
  • Expand into new markets and product lines.
  • Attract additional investment and strategic partnerships.

Threats

  • Failure to identify a suitable acquisition target.
  • Unfavorable deal terms or valuation.
  • Regulatory changes in the healthcare industry.
  • Economic downturn or market volatility.

Competitive Advantages

  • Management team's expertise in the healthcare industry.
  • Access to capital through the SPAC structure.
  • Network of relationships with potential target companies.
  • First-mover advantage in identifying attractive acquisition opportunities.

About ALPAU

Alpha Healthcare Acquisition Corp. III, incorporated in 2021 and based in New York, operates as a special purpose acquisition company (SPAC). The company's primary objective is to identify and complete a business combination, such as a merger, capital stock exchange, asset acquisition, stock purchase, or reorganization, with a company in the healthcare industry within the United States. As a SPAC, Alpha Healthcare Acquisition Corp. III does not have significant ongoing operations of its own. Instead, it exists solely to raise capital through an initial public offering (IPO) and then use those funds to acquire an existing private company, effectively taking that company public without the traditional IPO process. The company's success depends on its ability to find an attractive healthcare business that can deliver value to its shareholders. The management team's expertise in the healthcare sector and deal-making will be crucial in identifying and executing a successful transaction. The ultimate value for investors will be determined by the performance of the acquired company post-merger.

What They Do

  • Operate as a special purpose acquisition company (SPAC).
  • Focus on identifying and acquiring a business in the healthcare industry.
  • Raise capital through an initial public offering (IPO).
  • Seek a merger, capital stock exchange, or asset acquisition.
  • Target businesses in the United States.
  • Provide a vehicle for private healthcare companies to become publicly traded.

Business Model

  • Raise capital through an IPO to form a SPAC.
  • Identify and evaluate potential acquisition targets in the healthcare sector.
  • Negotiate and complete a merger or acquisition transaction.
  • Generate returns for shareholders through the growth and performance of the acquired company.

Industry Context

Alpha Healthcare Acquisition Corp. III operates within the SPAC market, a segment of the financial services industry characterized by companies formed to raise capital for future acquisitions. The SPAC market has experienced periods of rapid growth and increased scrutiny, with investors evaluating the quality of target companies and the terms of merger agreements. The competitive landscape includes numerous SPACs seeking deals in various sectors, including healthcare. Market trends such as increasing healthcare spending and innovation drive interest in healthcare-focused SPACs.

Key Customers

  • Institutional investors seeking exposure to the healthcare sector.
  • Retail investors interested in SPAC investments.
  • Private healthcare companies seeking to go public.
AI Confidence: 81% Updated: Mar 18, 2026

Financials

Chart & Info

Alpha Healthcare Acquisition Corp. III (ALPAU) stock price: Price data unavailable

Latest News

No recent news available for ALPAU.

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ALPAU.

Price Targets

Wall Street price target analysis for ALPAU.

MoonshotScore

49/100

What does this score mean?

The MoonshotScore rates ALPAU's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Rajiv Sarman Shukla

CEO

Rajiv Sarman Shukla serves as the CEO of Alpha Healthcare Acquisition Corp. III. His background includes extensive experience in the healthcare industry, with a focus on investment banking and mergers and acquisitions. He has held leadership positions at various financial institutions, advising healthcare companies on strategic transactions. His expertise spans across various healthcare sub-sectors, including pharmaceuticals, biotechnology, medical devices, and healthcare services. He brings a deep understanding of the healthcare landscape and a strong network of relationships within the industry.

Track Record: Under Rajiv Sarman Shukla's leadership, Alpha Healthcare Acquisition Corp. III is actively pursuing potential merger targets within the healthcare sector. His strategic decisions are centered around identifying companies with strong growth potential and attractive valuations. The company's success will be measured by its ability to complete a value-creating transaction and deliver returns to shareholders. His prior experience in M&A and investment banking positions him well to navigate the complexities of the SPAC market and identify promising opportunities.

What Investors Ask About Alpha Healthcare Acquisition Corp. III (ALPAU)

What does Alpha Healthcare Acquisition Corp. III do?

Alpha Healthcare Acquisition Corp. III is a special purpose acquisition company (SPAC) whose sole purpose is to identify and merge with a private company in the healthcare sector, effectively taking that company public. The company itself has no operating business. It raises capital through an initial public offering (IPO) and then seeks a suitable healthcare business to acquire. The value for investors is derived from the potential growth and performance of the acquired company after the merger is complete.

What do analysts say about ALPAU stock?

As a SPAC, analyst coverage on Alpha Healthcare Acquisition Corp. III is typically limited until a merger target is announced. The stock's performance is largely driven by speculation and expectations surrounding the potential acquisition target. Key valuation metrics will become more relevant once a target is identified and financial projections are available. Investors should carefully evaluate the terms of any proposed merger and the prospects of the acquired company before making investment decisions. Currently, AI analysis is pending for ALPAU.

What are the main risks for ALPAU?

The primary risk for Alpha Healthcare Acquisition Corp. III is the failure to identify and complete a suitable merger within the specified timeframe, which could lead to the liquidation of the SPAC and a loss of investment for shareholders. Other risks include unfavorable deal terms, regulatory changes in the healthcare industry, and economic downturns that could negatively impact the performance of the acquired company. Competition from other SPACs also poses a risk to finding an attractive target. Dilution is also a risk.

What regulatory challenges does Alpha Healthcare Acquisition Corp. III face?

As a SPAC, Alpha Healthcare Acquisition Corp. III faces regulatory scrutiny from the SEC regarding its IPO, disclosures, and merger process. The company must comply with securities laws and regulations, including those related to insider trading and conflicts of interest. The target healthcare company will also be subject to healthcare-specific regulations, such as HIPAA, FDA guidelines, and reimbursement policies. Compliance costs and potential liabilities could impact the financial performance of the combined company.

How does Alpha Healthcare Acquisition Corp. III create value for its shareholders?

Alpha Healthcare Acquisition Corp. III aims to create value for its shareholders by identifying and merging with a high-growth healthcare company that has the potential to generate significant returns. The management team's expertise in the healthcare industry and deal-making is crucial in selecting a target company with strong fundamentals and growth prospects. Successful execution of the merger and subsequent operational improvements can drive shareholder value through increased revenue, profitability, and market capitalization.

What are the key factors to evaluate for ALPAU?

Alpha Healthcare Acquisition Corp. III (ALPAU) currently holds an AI score of 49/100, indicating low score. Key strength: Experienced management team with healthcare expertise.. Primary risk to monitor: Potential: Failure to identify a suitable acquisition target within the specified timeframe.. This is not financial advice.

How frequently does ALPAU data refresh on this page?

ALPAU prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven ALPAU's recent stock price performance?

Recent price movement in Alpha Healthcare Acquisition Corp. III (ALPAU) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Experienced management team with healthcare expertise.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Information is based on publicly available sources and may be subject to change.
  • The analysis is limited by the lack of information regarding a specific acquisition target.
  • Investment in SPACs involves significant risks and is suitable for sophisticated investors.
Data Sources

Popular Stocks